14-day Premium Trial Subscription Try For FreeTry Free
RSI low/high Values: [ 25 - 75 ]
* StockInvest.us uses dynamically calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behavior.
AI Analysis of TARA
Powered by GPT-4
Upgraded!
Stock Analysis
Risk Assessment
Trading Strategy

Red day on Monday for Protara Therapeutics, Inc. stock after losing 0.344%
(Updated on May 06, 2024)

Sell candidate since Apr 30, 2024 Loss -2.68% PDF

The Protara Therapeutics, Inc. stock price fell by -0.344% on the last day (Monday, 6th May 2024) from $2.91 to $2.90. During the last trading day the stock fluctuated 4.51% from a day low at $2.88 to a day high of $3.01. The price has fallen in 7 of the last 10 days and is down by -4.92% for this period. Volume fell on the last day along with the stock, which is actually a good sign as volume should follow the stock. On the last day, the trading volume fell by -25 thousand shares and in total, 109 thousand shares were bought and sold for approximately $316.41 thousand.

The stock lies in the middle of a very wide and falling trend in the short term and further fall within the trend is signaled. Given the current short-term trend, the stock is expected to fall -19.23% during the next 3 months and, with a 90% probability hold a price between $1.99 and $3.29 at the end of this 3-month period.

Ready to grow your portfolio? Here's your beginner's guide to opening a free brokerage account.

TARA Signals & Forecast

There are mixed signals in the stock today. The Protara Therapeutics, Inc. stock holds sell signals from both short and long-term Moving Averages giving a more negative forecast for the stock. Also, there is a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections up, there will be some resistance from the lines at $2.95 and $3.38. A break-up above any of these levels will issue buy signals. Volume fell along with the price during the last trading day, which is technical positive. One should, however, note that this stock may have low liquidity in periods, which increases the general risk. A buy signal was issued from a pivot bottom point on Friday, April 19, 2024, and so far it has risen 9.85%. Further rise is indicated until a new top pivot has been found. Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD).

Support, Risk & Stop-loss for Protara Therapeutics, Inc. stock

Protara Therapeutics, Inc. finds support from accumulated volume at $2.89 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock has average movements during the day, but be aware of low or falling volume as this increases the risk. During the last day, the stock moved $0.130 between high and low, or 4.51%. For the last week the stock has had daily average volatility of 6.97%.

Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.

Trading Expectations (TARA) For The Upcoming Trading Day Of Tuesday 7th

For the upcoming trading day on Tuesday, 7th we expect Protara Therapeutics, Inc. to open at $2.93, and during the day (based on 14 day Average True Range), to move between $2.61 and $3.19, which gives a possible trading interval of +/-$0.285 (+/-9.84%) up or down from last closing price. If Protara Therapeutics, Inc. takes out the full calculated possible swing range there will be an estimated 19.68% move between the lowest and the highest trading price during the day.

Since the stock is closer to the support from accumulated volume at $2.89 (0.34%) than the resistance at $3.00 (3.45%), our systems sees the trading risk/reward intra-day as attractive and believe profit can be made before the stock reaches first resistance..

Is Protara Therapeutics, Inc. stock A Buy?

Protara Therapeutics, Inc. holds several negative signals and we believe that it will still perform weakly in the next couple of days or weeks. We, therefore, hold a negative evaluation of this stock.

Current score: -2.909 Sell Candidate Unchanged

Predicted Opening Price for Protara Therapeutics, Inc. of Tuesday, May 7, 2024

Fair opening price May 7, 2024 Current price
$2.93 ( 1.03%) $2.90

The predicted opening price is based on yesterday's movements between high, low, and closing price.

Trading levels for TARA

Fibonacci Support & Resistance Levels

Level Price
Resistance R3 3.06 5.52 %
R2 3.01 3.80 %
R1 2.98 2.75 %
Current price: 2.90
Support S1 2.88 -0.678 %
S2 2.85 -1.74 %
S3 2.80 -3.45 %

Accumulated Volume Support & Resistance Levels

Level Price
Resistance R3 3.10 6.90 %
R2 3.05 5.17 %
R1 3.00 3.45 %
Current price 2.90
Support S1 2.89 -0.345%
S2 2.82 -2.76%
S3 2.75 -5.17%

FAQ

What is the symbol for Protara Therapeutics, Inc. Stock and on which exchange is it traded?
The symbol for Protara Therapeutics, Inc. is TARA and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell Protara Therapeutics, Inc. Stock?
Protara Therapeutics, Inc. holds several negative signals and we believe that it will still perform weakly in the next couple of days or weeks. We, therefore, hold a negative evaluation of this stock.

How to buy Protara Therapeutics, Inc. Stock?
Protara Therapeutics, Inc. Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Protara Therapeutics, Inc. Stock.

What's the current price of Protara Therapeutics, Inc. Stock?
As of the end of day on the May 06, 2024, the price of an Protara Therapeutics, Inc. (TARA) share was $2.90.

What is the 52-week high and low for Protara Therapeutics, Inc. Stock?
The 52-week high for Protara Therapeutics, Inc. Stock is $1,438.17 and the 52-week low is $615.86.

What is the market capitalization of Protara Therapeutics, Inc. Stock?
As of the May 06, 2024, the market capitalization of Protara Therapeutics, Inc. is 59.711M.

When is the next earnings date for Protara Therapeutics, Inc.?
The upcoming earnings date for Protara Therapeutics, Inc. is Aug 01, 2024.
Click to get the best stock tips daily for free!

About Protara Therapeutics, Inc.

Protara Therapeutics. Protara Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the identifying and advancing transformative therapies for the treatment of cancer and rare diseases. The company's lead program is TARA-002, an investigational cell therapy for the treatment of lymphatic malformations. It also develops intravenous choline chloride, an investigational phospholipid substrate replacement therapy for the treatment of intestinal failur... TARA Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT